ZA936260B - Novel antibodies for conferring passive immunity against infection by a pathogen in man - Google Patents
Novel antibodies for conferring passive immunity against infection by a pathogen in manInfo
- Publication number
- ZA936260B ZA936260B ZA936260A ZA936260A ZA936260B ZA 936260 B ZA936260 B ZA 936260B ZA 936260 A ZA936260 A ZA 936260A ZA 936260 A ZA936260 A ZA 936260A ZA 936260 B ZA936260 B ZA 936260B
- Authority
- ZA
- South Africa
- Prior art keywords
- pathogen
- man
- immunity against
- against infection
- passive immunity
- Prior art date
Links
- 230000036039 immunity Effects 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 244000052769 pathogen Species 0.000 title 1
- 230000001717 pathogenic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
- C07K16/205—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94165492A | 1992-09-09 | 1992-09-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA936260B true ZA936260B (en) | 1994-03-18 |
Family
ID=25476840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA936260A ZA936260B (en) | 1992-09-09 | 1993-08-26 | Novel antibodies for conferring passive immunity against infection by a pathogen in man |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0659192A4 (en) |
| JP (1) | JPH08500979A (en) |
| KR (1) | KR950703573A (en) |
| CN (1) | CN1087681A (en) |
| AU (1) | AU4851193A (en) |
| CA (1) | CA2143417A1 (en) |
| NZ (1) | NZ256232A (en) |
| WO (1) | WO1994005690A1 (en) |
| ZA (1) | ZA936260B (en) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996009398A1 (en) * | 1994-09-19 | 1996-03-28 | Rijkslandbouwuniversiteit Wageningen | Gene constructs encoding crop-protecting agents, as well as transformed plants containing and expressing such constructs, and methods of controlling plague organisms and pathogens in crops |
| SE9500148D0 (en) * | 1995-01-18 | 1995-01-18 | Bioinvent Internatioal Ab | Antibodies for use in cancer therapy and diagnosis |
| AUPP221098A0 (en) | 1998-03-06 | 1998-04-02 | Diatech Pty Ltd | V-like domain binding molecules |
| US6455677B1 (en) | 1998-04-30 | 2002-09-24 | Boehringer Ingelheim International Gmbh | FAPα-specific antibody with improved producibility |
| EP0953639A1 (en) * | 1998-04-30 | 1999-11-03 | Boehringer Ingelheim International GmbH | FAPalpha-specific antibody with improved producibility |
| AU2008200400B2 (en) * | 2001-01-17 | 2012-06-07 | Aptevo Research And Development Llc | Binding domain-immunoglobulin fusion proteins |
| CN1268394C (en) * | 2001-01-17 | 2006-08-09 | 特鲁比昂药品公司 | Binding domain-immunoglobulin fusion proteins |
| US20030133939A1 (en) | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
| US7829084B2 (en) | 2001-01-17 | 2010-11-09 | Trubion Pharmaceuticals, Inc. | Binding constructs and methods for use thereof |
| US7754208B2 (en) | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
| BR0207068A (en) | 2001-01-26 | 2004-12-21 | Inhibitex Inc | Clfa protein monoclonal antibody, isolated antiserum, isolated antibody and humanized antibody containing said antibody, diagnostic kit comprising said antibody, method for diagnosing an infection with s.aureus, pharmaceutical composition for treating or preventing said infection , method for inducing an immune response, method for identifying monoclonal antibodies to clfa protein and active fragment isolated from s.aureus clfa protein a |
| WO2004111233A1 (en) | 2003-06-11 | 2004-12-23 | Chugai Seiyaku Kabushiki Kaisha | Process for producing antibody |
| US7754209B2 (en) | 2003-07-26 | 2010-07-13 | Trubion Pharmaceuticals | Binding constructs and methods for use thereof |
| TW200530269A (en) | 2003-12-12 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Anti-Mpl antibodies |
| WO2006106905A1 (en) * | 2005-03-31 | 2006-10-12 | Chugai Seiyaku Kabushiki Kaisha | Process for production of polypeptide by regulation of assembly |
| TW200722518A (en) | 2005-03-31 | 2007-06-16 | Chugai Pharmaceutical Co Ltd | Sc(fv)2 structural isomers |
| JP5085322B2 (en) | 2005-06-10 | 2012-11-28 | 中外製薬株式会社 | Pharmaceutical composition containing sc (Fv) 2 |
| US8945543B2 (en) | 2005-06-10 | 2015-02-03 | Chugai Seiyaku Kabushiki Kaisha | Stabilizer for protein preparation comprising meglumine and use thereof |
| US10307481B2 (en) | 2005-07-25 | 2019-06-04 | Aptevo Research And Development Llc | CD37 immunotherapeutics and uses thereof |
| JP5144499B2 (en) | 2006-03-31 | 2013-02-13 | 中外製薬株式会社 | Antibody modification method for purifying bispecific antibodies |
| DK2006381T3 (en) | 2006-03-31 | 2016-02-22 | Chugai Pharmaceutical Co Ltd | PROCEDURE FOR REGULATING ANTIBODIES BLOOD PHARMACOKINETICS |
| RU2487888C2 (en) | 2006-06-12 | 2013-07-20 | ЭМЕРДЖЕНТ ПРОДАКТ ДИВЕЛОПМЕНТ СИЭТЛ, ЭлЭлСи | Single-chain multivalent binding proteins with effector function |
| DK2202245T3 (en) | 2007-09-26 | 2016-11-21 | Chugai Pharmaceutical Co Ltd | A method of modifying an antibody isoelectric point VIA amino acid substitution in CDR |
| ES2566957T3 (en) | 2007-09-26 | 2016-04-18 | Chugai Seiyaku Kabushiki Kaisha | Constant region of modified antibody |
| NZ603059A (en) | 2008-04-11 | 2014-07-25 | Emergent Product Dev Seattle | Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
| EP2409991B1 (en) | 2009-03-19 | 2017-05-03 | Chugai Seiyaku Kabushiki Kaisha | Antibody constant region variant |
| TWI682995B (en) | 2009-03-19 | 2020-01-21 | 日商中外製藥股份有限公司 | Antibody constant region alteration |
| CA2780713A1 (en) * | 2009-09-03 | 2011-03-10 | Vancouver Biotech Ltd. | Monoclonal antibodies against gonadotropin-releasing hormone receptor |
| JP5837821B2 (en) | 2009-09-24 | 2015-12-24 | 中外製薬株式会社 | Antibody constant region variants |
| WO2011108714A1 (en) | 2010-03-04 | 2011-09-09 | 中外製薬株式会社 | Antibody constant region variant |
| PH12013500974A1 (en) | 2010-11-17 | 2013-07-08 | Chugai Pharmaceutical Co Ltd | Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii |
| ES2732712T3 (en) | 2011-10-31 | 2019-11-25 | Chugai Pharmaceutical Co Ltd | Antigen binding molecule that has a regulated conjugation between the heavy chain and the light chain |
| US20140271462A1 (en) | 2013-03-13 | 2014-09-18 | Imaginab, Inc. | Antigen binding constructs to cd8 |
| SG10201803449VA (en) | 2013-09-27 | 2018-05-30 | Chugai Pharmaceutical Co Ltd | Method for producing polypeptide heteromultimer |
| FR3025517B1 (en) | 2014-09-10 | 2016-12-23 | Repropharm | LIGANDS POTENTIATING THE BIOACTIVITY OF GONADOTROPHINS |
| MA40764A (en) | 2014-09-26 | 2017-08-01 | Chugai Pharmaceutical Co Ltd | THERAPEUTIC AGENT INDUCING CYTOTOXICITY |
| JP7082484B2 (en) | 2015-04-01 | 2022-06-08 | 中外製薬株式会社 | Method for Producing Polypeptide Heterogeneous Multimer |
| JP7026613B2 (en) | 2015-08-07 | 2022-02-28 | イマジナブ・インコーポレーテッド | Antigen binding construct for target molecule |
| UA126278C2 (en) | 2015-09-21 | 2022-09-14 | Аптево Рісьорч Енд Девелопмент Ллс | Cd3 binding polypeptides |
| WO2017115773A1 (en) | 2015-12-28 | 2017-07-06 | 中外製薬株式会社 | Method for promoting efficiency of purification of fc region-containing polypeptide |
| RU2746754C2 (en) | 2016-03-14 | 2021-04-20 | Чугаи Сейяку Кабусики Кайся | Cell damage inducing therapeutic medicinal product for anticancer therapy |
| UA126900C2 (en) | 2016-04-28 | 2023-02-22 | Чугаі Сейяку Кабусікі Кайся | ANTIBODY CONTAINING DRUG |
| WO2018147960A1 (en) | 2017-02-08 | 2018-08-16 | Imaginab, Inc. | Extension sequences for diabodies |
| JPWO2019088143A1 (en) | 2017-11-01 | 2020-11-12 | 中外製薬株式会社 | Antibody variants and isoforms with reduced bioactivity |
| CN117854601B (en) * | 2024-03-04 | 2024-05-14 | 鲁东大学 | A method for determining complementary regions based on gene type and amino acid sequence |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4632909A (en) * | 1983-10-31 | 1986-12-30 | The United States Of America As Represented By The Department Of Health And Human Services | Monoclonal antibodies which block infectivity of malarial parasites to mosquitoes |
| JPS63267295A (en) * | 1986-12-03 | 1988-11-04 | Sumitomo Chem Co Ltd | Human antibody, antibody gene and corresponding recombinant |
-
1993
- 1993-08-26 ZA ZA936260A patent/ZA936260B/en unknown
- 1993-09-08 CA CA002143417A patent/CA2143417A1/en not_active Abandoned
- 1993-09-08 EP EP93921412A patent/EP0659192A4/en not_active Withdrawn
- 1993-09-08 JP JP6507519A patent/JPH08500979A/en active Pending
- 1993-09-08 WO PCT/US1993/008435 patent/WO1994005690A1/en not_active Ceased
- 1993-09-08 AU AU48511/93A patent/AU4851193A/en not_active Abandoned
- 1993-09-08 NZ NZ256232A patent/NZ256232A/en unknown
- 1993-09-09 CN CN93119080A patent/CN1087681A/en active Pending
-
1995
- 1995-03-09 KR KR1019950700936A patent/KR950703573A/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| KR950703573A (en) | 1995-09-20 |
| JPH08500979A (en) | 1996-02-06 |
| EP0659192A4 (en) | 1996-09-11 |
| EP0659192A1 (en) | 1995-06-28 |
| WO1994005690A1 (en) | 1994-03-17 |
| CA2143417A1 (en) | 1994-03-17 |
| CN1087681A (en) | 1994-06-08 |
| NZ256232A (en) | 1997-02-24 |
| AU4851193A (en) | 1994-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA936260B (en) | Novel antibodies for conferring passive immunity against infection by a pathogen in man | |
| AU113430S (en) | A bottle | |
| EP0497471A3 (en) | A technique for improving esd immunity | |
| GB2265221B (en) | Inductive sensors | |
| AU111329S (en) | A bottle | |
| AU111447S (en) | A bottle | |
| IL96561A0 (en) | Amorphous silicon sensor | |
| GB9205257D0 (en) | A lifting device | |
| GB9201054D0 (en) | Impact sensing device | |
| GB9206203D0 (en) | Inductive sensors | |
| GB9202926D0 (en) | A reinforcement device | |
| AU110494S (en) | A bottle | |
| GB9102059D0 (en) | A vehicle suspension device | |
| EP0465815A3 (en) | Method to palletize textile packages | |
| GB2272976B (en) | A sensor | |
| GB9121891D0 (en) | A device for gripping differently sized objects | |
| GB9025142D0 (en) | Intelligent vibration sensor | |
| GB9211116D0 (en) | Inductive sensor | |
| GB9026694D0 (en) | A damping device | |
| DK0575970T3 (en) | Bag containing a concentrate | |
| GB2296977B (en) | Semi-conductor acceleration sensor | |
| KR950022557U (en) | Bag shoulder | |
| IL127163A0 (en) | A vaccine which provides protective immunity against a bacterial pathogen | |
| CS524390A3 (en) | Optoelectronic tactile sensor | |
| BR7201652U (en) | handle adaptable to different packaging |